Inventor · disambiguated record
Gregory F. Brooks
Also filed as: BROOKS GREGORY F
13 granted patents·25 pending applications·493 citations·filing 2000–2025
93Inventor score
Files withALLERGAN INC27AEON BIOPHARMA INC7AEON BIOPHARMA SUB INC2ALLERGAN SALES INC1HAAG-MOLKENTELLER CORNELIA C1
Top patents by PatentIndex Score
38 records- 0198US6767544B2Methods for treating cardiovascular diseases with botulinum toxinALLERGAN INC·Filed 2002·Granted Jul 27, 2004·147 cites·14 claims
- 0298US6423319B1Methods for treating muscle injuriesALLERGAN SALES INC·Filed 2000·Granted Jul 23, 2002·226 cites·11 claims
- 0396US7794386B2Methods for facilitating weight lossALLERGAN INC·Filed 2006·Granted Sep 14, 2010·34 cites·33 claims
- 0492US7811586B2Methods for alleviating testicular painALLERGAN INC·Filed 2006·Granted Oct 12, 2010·13 cites·26 claims
- 0589US7223399B2Methods for treating restenosis with a botulinum neurotoxinALLERGAN INC·Filed 2006·Granted May 29, 2007·4 cites·14 claims
- 0689US6955813B2Therapy for injured musclesALLERGAN INC·Filed 2002·Granted Oct 18, 2005·26 cites·10 claims
- 0785US7140371B2Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxinsALLERGAN INC·Filed 2004·Granted Nov 28, 2006·25 cites·19 claims
- 0880US11826405B2Neurotoxin compositions for use in treating headacheAEON BIOPHARMA INC·Filed 2020·Granted Nov 28, 2023·1 cites·30 claims
- 0975US7468188B2Multi-step therapy for injured musclesALLERGAN INC·Filed 2006·Granted Dec 23, 2008·1 cites·13 claims
- 1073US2024050540A1Neurotoxin compositions for use in treating headacheAEON BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1171US7048927B2Botulinum neurotoxin eluting stentALLERGAN INC·Filed 2003·Granted May 23, 2006·9 cites·5 claims
- 1269US7108857B2Therapy for injured musclesALLERGAN INC·Filed 2004·Granted Sep 19, 2006·2 cites·10 claims
- 1366US7494654B2Compositions and methods for treating cardiovascular conditions with botulinum toxinALLERGAN INC·Filed 2004·Granted Feb 24, 2009·5 cites·10 claims
- 1466US2025134970A1Neurotoxin compositions for use in treating headacheAEON BIOPHARMA SUB INC·Filed 2025·Application pending·0 cites
- 1566US2007140968A1Method for determining botulinum potencyALLERGAN INC·Filed 2006·Application pending·0 cites
- 1666US2007134158A1Method for comparing multiple botulinum neurotoxinsALLERGAN INC·Filed 2006·Application pending·0 cites
- 1766US2007140969A1Method for comparing botulinum neurotoxinsALLERGAN INC·Filed 2006·Application pending·0 cites
- 1864US9492513B2Methods for treatment of hip and groin pain associated with femoroacetabular impingement (FAI)ALLERGAN INC·Filed 2014·Granted Nov 15, 2016·0 cites·20 claims
- 1964US2009220568A1Methods for treating a stricture with a botulinum toxinALLERGAN INC·Filed 2009·Application pending·0 cites
- 2060US2024252603A1Neurotoxin compositions for use in treating headacheAEON BIOPHARMA SUB INC·Filed 2022·Application pending·0 cites
- 2159US2008153880A1Pan-alpha-2 receptor agonist and acid reducer compositions for treating gastrointestinal motility disordersALLERGAN INC·Filed 2007·Application pending·0 cites
- 2259US2008153832A1Pan-alpha-2 receptor agonist and relaxant compositions for treating gastrointestinal motility disordersALLERGAN INC·Filed 2007·Application pending·0 cites
- 2359US2008153829A1Pan-alpha-2 receptor agonist and 5ht4 serotonin receptor compositions for treating gastrointestinal motility disordersALLERGAN INC·Filed 2007·Application pending·0 cites
- 2458US2025249081A1Neurotoxin compositions for use in modulating stellate ganglion activityAEON BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2557US2025064906A1Neurotoxin compositions for use in treating digestive disordersAEON BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2657US2006216313A1Methods for treating a stricture with a botulinum toxinALLERGAN INC·Filed 2006·Application pending·0 cites
- 2757US2005214327A1Neurotoxin-containing suppositories and related methodsALLERGAN INC·Filed 2004·Application pending·0 cites
- 2853US2022331410A1Neurotoxin compositions for use in treating gastroparesisAEON BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2950US2008092910A1Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric proceduresALLERGAN INC·Filed 2006·Application pending·0 cites
- 3050US2014100666A1Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric proceduresALLERGAN INC·Filed 2013·Application pending·0 cites
- 3148US2013171122A1Endopeptidase and neurotoxin combination treatment of bladder disordersALLERGAN INC·Filed 2012·Application pending·0 cites
- 3248US2008153825A1Alpha-2b receptor agonist and 5ht4 serotonin receptor compositions for treating gastrointestinal motility disordersALLERGAN INC·Filed 2007·Application pending·0 cites
- 3348US2009287161A1Metered, multiple dose/aliquot syringeALLERGAN INC·Filed 2008·Application pending·0 cites
- 3448US2008153927A1Alpha-2b receptor agonist and relaxant compositions for treating gastrointestinal motility disordersALLERGAN INC·Filed 2007·Application pending·0 cites
- 3548US2008153881A1Alpha-2b receptor agonist and acid reducer compositions for treating gastrointestinal motility disordersALLERGAN INC·Filed 2007·Application pending·0 cites
- 3648US2023145940A1Neurotoxin compositions for use in treating cardiovascular disordersAEON BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3747US2022296687A1Neurotoxin compositions for use in treating neurologic and psychiatric disordersAEON BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3827US2012195878A1Protocol for the administration of botulinum toxinsHAAG-MOLKENTELLER CORNELIA C·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory F. Brooks files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →